Biomarker Subgroup Analyses Pretreated KRAS G12C-Mutated NSCLC Patients Benefit from Sotorasib Lung 3 Mins Read1 Ferdinandos Skoulidis, MD, PhD, from the MD Anderson Cancer Center, presented the results of biomarker subgroup analyses from the phase…
